In a harshly worded letter dated July 16, the FDA told Pfizer to stop false advertising for injectable Geodon, an antipsychotic medicine used for agitation. The FDA said the giant pharmaceutical had exaggerated benefits and omitted risks of the injectable drug. The letter was posted on the FDA website August 13, but agency concerns go back at least five years. In September 2002, the FDA also warned Pfizer about misleading advertising that minimized the risk of this drug.
